The Role of Nitric Oxide and Vasopressin in Refractory Right Heart Failure

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 9, Issue 1, 2004, Pages 9-11

  Wasson, Sanjeev ^a   Govindarajan, Gurushankar ^a,b   Reddy, H K ^a   Flaker, Gregory ^a  

^a University of Missouri   (United States)

^b Department of Internal Medicine ^*  (United States)

Author keywords

Inhaled nitric oxide; Right heart failure; Vasopressin

Indexed keywords

DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; NITRATE; NITRIC OXIDE; VASOPRESSIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CENTRAL VENOUS PRESSURE; CORONARY STENT; DIARRHEA; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; HYPOTENSION; LEG EDEMA; PRIORITY JOURNAL; RESUSCITATION; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING;

EID: 1942478377     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840400900i102     Document Type: Article

References (12)

1. Eugene Braunwald. Heart Failure. Harrison Internal Medicine. McGraw-Hill, New York, pp 1036-1096, 2001
2. Andersen HR, Falk E, Nielsen D. Right ventricular infarction: Frequency, size and topography in coronary heart disease: A prospective study comprising 107 consecutive autopsies from a coronary care unit. J Am Coll Cardiology 10:1223-1232, 1987
3. Goldstein J. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 40:841, 2002
4. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149:538-551, 1994
5. Nong Z, Hoylaerts M, Van Pelt N, et al. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats. Circ Res 81:865-869, 1997
6. Rimar S, Gillis NC. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88:2884-2887, 1993
7. Spalding MB, Ala-Kokk T, Kiviluoma K, et al. Inhaled nitric oxide effectively decreases right heart afterload following right heart infarct in pigs. Scand Cardiovasc J 35:45-49, 2001
8. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 151:38438-38439, 1995
9. Leather HA, Segers P, Berends N, et al. Effects of vasopressin on the right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 30:2604-2605, 2002
10. Holmes CL, Patel BM, Russel JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 120:989-1002, 2001
11. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of Arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 96:286-290, 1997
12. Helman DN, Oz MC. Developing a comprehensive mechanical support program. J Cardiac Surg 16:203-208, 2001